Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06361888
Status:
RECRUITING
Last Update Posted:
2024-05-14
First Post:
2024-03-26
Brief Title:
A Phase IIIII Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab Nab-paclitaxel and Gemcitabine in Metastatic Pancreatic Cancer
Sponsor:
Hutchmed
Organization:
Hutchmed
Organization Data
Organization:
Hutchmed
Class:
INDUSTRY
Study ID:
2023-012-00CH1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hutchmed
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None